Aceae Nutra is an IP focused agri-tech SME founded in 2018 on innovation and product development. Aceae Nutra’s approach incorporates a pharmaceutical development plan, alongside plant sciences and agronomic expertise to generate viable plant-based solutions for conditions affecting human and animal health.  

Together with corporate partners and academic researchers, the Aceae Nutra team is developing novel antivirals for the mitigation of agronomic and pandemic class viruses in agri-livestock, aquaculture, companion animals and humans. The treatments include anti-inflammatories and those that alleviate the distressing symptoms of autism spectrum disorder and Alzheimer's